<!DOCTYPE html>
<html>
<head>
	<title>Genomics England - Rare Diseases - Brugada syndrome</title>
	<meta charset="utf-8" />
	<script type="text/javascript" src="inc/jquery.min.js"></script>
	<link rel="stylesheet" type="text/css" href="inc/style.css" />
	<!-- <script src="../file/js/modernizr.js"></script>  -->
</head>
<body>
	<div class="container">
		<h1>Brugada syndrome</h1>
		<div id="nav">
			<br /><br /><a href="index.html" style="margin-left:20px;">&#171; Back to homepage</a>
		</div>			
		<div class="main">
			<ul class="tabs">
				<li>
					<input type="radio" checked name="tabs" id="tab1">
					<label for="tab1">Eligibility</label>
					<div id="tab-content1" class="tab-content animated fadeIn">
						<!-- <h2>Brugada Eligibility</h2> -->
Relevant diseases: - Brugada syndrome

<h3>Inclusion Criteria</h3>
<br />
<br />
Brugada syndrome diagnosed according to criteria*: <br />
- ST segment elevation with type I morphology ≥2 mm in ≥ 1 lead among the right precordial leads V1,V2 positioned in the 2nd, 3rd, or 4th intercostal space occurring spontaneously. <br />
OR<br />
- a type I ECG morphology as above following a provocative drug test with intravenous administration of Class I antiarrhythmic drugs.<br />
AND one or both of the two criteria below:<br />
a family history of:<br />
- premature sudden death (<40 years old) or autopsy negative sudden death <65 years old: the sudden arrhythmic death syndrome (SADS)<br />
<br />
AND/OR<br />
<br />
- other relatives with a diagnosis of BrS (spontaneous or drug-induced; symptomatic or asymptomatic)<br />
<br />
* Heart Rhythm Society/European Heart Rhythm Association

<h3>Exclusion Criteria</h3>
- Unclear diagnosis or history suggestive of a non-genetic cause<br />
- Any Brugada syndrome mutation positive (if clearly pathogenic)

<h3>Prior Genetic Testing</h3>
- Results should have been reviewed for all genetic tests undertaken. This includes review of available exome sequencing data, but where this is the case can be limited to genes specified within disease-relevant in silico panels. The patient is not eligible if a pathogenic variant has been identified in any gene related to their phenotype.<br />
- Standard local genetic testing and nationally commissioned testing for this phenotype should have been completed AND<br />
- Testing should be undertaken for any individual gene for which diagnostic yield is >10% for this phenotype AND<br />
- The following specific gene tests are advised as a means of limiting the re-discovery of recognised pathogenic variants that could be more efficiently identified through the existing catalogue of UKGTN tests:

<h3>Genes</h3>
- SCN5A

<h3>Closing Statement</h3>
These requirements will be kept under continual review during the main programme and may be subject to change.

					</div>
				</li>
				<li>
					<input type="radio" name="tabs" id="tab2">
					<label for="tab2">Phenotypes</label>
					<div id="tab-content2" class="tab-content animated fadeIn">
						<!-- <h2>Arrhythmia Phenotypes</h2> -->

	<h3><a href="http://purl.obolibrary.org/obo/HP_0001695" onclick="window.open(this.href);return false;">Cardiac arrest</a></h3>
	
	<h3><a href="http://purl.obolibrary.org/obo/HP_0001279" onclick="window.open(this.href);return false;">Syncope</a></h3>
	Syncope refers to a generalized weakness of muscles with loss of postural tone, inability to stand upright, and loss of consciousness. Once the patient is in a horizontal position, blood flow to the brain is no longer hindered by gravitation and consciousness is regained. Unconsciousness usually lasts for seconds to minutes. Headache and drowsiness (which usually follow seizures) do not follow a syncopal attack. Syncope results from a sudden impairment of brain metabolism usually due to a reduction in cerebral blood flow.
	<h3><a href="http://purl.obolibrary.org/obo/HP_0001962" onclick="window.open(this.href);return false;">Palpitations</a></h3>
	A sensation that the heart is pounding or racing, which is a non-specific sign but may be a manifestation of arrhythmia.
	<h3><a href="http://purl.obolibrary.org/obo/HP_0004756" onclick="window.open(this.href);return false;">Ventricular tachycardia</a></h3>
	
	<h3><a href="http://purl.obolibrary.org/obo/HP_0011704" onclick="window.open(this.href);return false;">Sick sinus syndrome</a></h3>
	
	<h3><a href="http://purl.obolibrary.org/obo/HP_0001678" onclick="window.open(this.href);return false;">Atrioventricular block</a></h3>
	Delayed or lack of conduction of atrial depolarizations through the atrioventricular node to the ventricles.
	<h3><a href="http://purl.obolibrary.org/obo/HP_0011710" onclick="window.open(this.href);return false;">Bundle branch block</a></h3>
	Block of conduction of electrical impulses along the Bundle of His or along one of its bundle branches.<br />
<br />
Comment:<br />
The Bundle of His conducts the electrical impulse from the atrioventricular node into the ventricles. THe Bundle of His divides into right and left bundle branches. A universal feature of a bundle branch block is a prolongation of the time required for depolarization of a portion of the ventricles, reflected in an abnormality of the QRS complex.
	<h3><a href="http://purl.obolibrary.org/obo/HP_0004308" onclick="window.open(this.href);return false;">Ventricular arrhythmia</a></h3>
	
	<h3><a href="http://purl.obolibrary.org/obo/HP_0001692" onclick="window.open(this.href);return false;">Primary atrial arrhythmia</a></h3>
	A type of supraventricular tachycardia in which the atria are the principal site of electrophysiologic disturbance.

					</div>
				</li>
				<li>
					<input type="radio" name="tabs" id="tab3">
					<label for="tab3">Clinical Tests</label>
					<div id="tab-content3" class="tab-content animated fadeIn">
						<!-- <h2>Arrhythmia Clinical Tests</h2> -->

<ul>
	<li><strong>ECG diagnostics</strong><br />Cardiac measurements made using electrocardiography</li>
	<li><strong>Cardiac MRI</strong><br /></li>
	<li><strong>Holter monitor test</strong><br /></li>
	<li><strong>Signal averaged ECG</strong><br /></li>
	<li><strong>Echocardiogram</strong><br />Applicable to all echocardiograms, i.e. cardiomyopathy and CTD</li>
	<li><strong>Electrophysiological study</strong><br />Electrophysiological or EP study</li>
	<li><strong>Alcohol intake</strong><br /></li>
	<li><strong>Exercise status</strong><br /></li>
	<li><strong>Exercise test - cardiac</strong><br />Exercise test used as part of cardiac diagnostic testing</li>
	<li><strong>Epinephrine challenge</strong><br />A cardiac drug challenge test using epinephrine</li>
	<li><strong>Sodium channel blocker challenge</strong><br />A cardiac drug challenge using sodium channel blocker</li>
	<li><strong>Smoking status</strong><br /></li>
</ul>
					</div>
				</li>				
			</ul>
		</div>		
	</div>		
</body>
</html>